POM-V Prescription Required

Bovilis INtranasal RSP Live, Nasal Spray, Lyophilisate and Solvent for Suspension for Cattle

Active ingredients: Bovine parainfluenza virus 3, Bovine respiratory syncytial virus

Form

Spray

Species

Cattle

Manufacturer

Intervet International B.V.

VMD MA No.

06376/5024

What it's used for

For active immunisation of calves from the day of birth onwards to reduce clinical signs of respiratory disease and viral shedding from infection with BRSV...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Bovine parainfluenza virus 3...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Bovilis INtranasal RSP Live, Nasal Spray, Lyophilisate and Solvent for Suspension for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For active immunisation of calves from the day of birth onwards to reduce clinical
signs of respiratory disease and viral shedding from infection with BRSV and PI3.
Onset of immunity: BRSV: 6 days (for calves vaccinated from the day of birth
onwards);
5 days (for calves vaccinated from the age of 1 week
onwards);
PI3: 1 week.
Duration of immunity: 12 weeks.

None.

Revised: January 2025
AN: 02650/2024

Cattle:
Very common
(>1 animal / 10 animals treated):
Nasal discharge
.
Elevated temperature
.
Common
(1 to 10 animals / 100 animals
treated):
Cough
, increased respiratory rate
.
Ocular discharge
.
Mild and transient. Occurs during two days following vaccination.
Minor and transient (very rarely up to 41.1 °C); normally resolves within four days.
Mild and transient. Normally resolves in three days.
Transient. Normally resolves within four days.
Mild and transient. Normally resolves in two days.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Vaccinate healthy animals only.
Animals should be preferably vaccinated at least 5 – 7 days before a period of stress
or increased infection pressure.
The efficacy against BRSV may be reduced by presence of maternally derived
antibodies.

Special precautions for use in animals
Vaccinated calves may excrete the vaccine strains up to 12 days following
vaccination.
It is recommended to vaccinate all calves of the herd.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Not applicable.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.

Safety and efficacy data are available which demonstrate that this vaccine can be
administered on the same day but not mixed with Bovilis Nasalgen-C. The vaccines
should be given into different nostrils. The product information of that veterinary
medicinal product should be consulted before administration.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product except the product mentioned above.
A decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case by case basis.

Lyophilisate:
Store in a refrigerator (2 C – 8 C).
Do not freeze. Protect from light.
Solvent:
Store below 25 °C if stored independently from the lyophilisate.
Do not freeze.

TCID50*
Live bovine parainfluenza virus type 3 (PI3), strain INT2-2013: 4.8 – 7.3 log10 TCID50*
*50% tissue culture infective dose
Excipients:
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.